Linaclotide

Constella 290 microgramos capsulas duras

0,290 mg cápsula duraSpainMarketedAuthorised 12 Mar 2013

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Linaclotide

Constella 290 microgramos capsulas duras

0,290 mg cápsula duraSpainMarketedAuthorised 12 Mar 2013

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Linzess

United States · 145MCG, 290MCG, 72MCG · capsule · Abbvie

LinaclotideUnited States · 145MCG, 290MCG, 72MCG · capsule · Actavis Labs FL INC

LinzessSaudi Arabia · Forest Laboratories Ireland Limited

Packs

Pack	Code	Status
Constella 290 microgramos capsulas duras Frasco con 28 cápsulas	697254

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Linaclotide
Strength: 0,290 mg
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 12 Mar 2013
Registration: 112801002
Marketing authorisation holder: Abbvie Deutschland Gmbh & Co. Kg
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica